Advanced Medical Isotope Corp. (ADMD) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Advanced Medical Isotope Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 320,363 360,613 393,603 247,968 140,603
Cost of Goods Sold (COGS) incl. D&A 1.12M 1.47M 1.36M 556,020 1.76M
COGS excluding D&A 558,860 923,771 815,530 72,820 1.55M
Depreciation & Amortization Expense 562,671 545,192 546,388 483,200 208,632
Depreciation 537,671 539,499 539,720 472,038 199,743
Amortization of Intangibles 25,000 5,693 6,668 11,162 8,889
Gross Income (801,168) (1.11M) (968,315) (308,052) (1.62M)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.75M 2.47M 1.59M 5.56M 1.96M
Research & Development 67,006 - 481,677 973,611 416,161
Other SG&A 1.68M 2.47M 1.11M 4.59M 1.54M
Other Operating Expense 0 0 0 0 0
Unusual Expense 602,718 122,500 0 2.29M (1.44M)
EBIT after Unusual Expense (602,718) (122,500) 0 (2.29M) 1.44M
Non Operating Income/Expense 0 502,466 220,727 0 0
Non-Operating Interest Income 0 599 - 0 0
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 839,627 860,252 408,474 1.1M 1.6M
Gross Interest Expense 839,627 860,252 408,474 1.1M 1.6M
Interest Capitalized 0 0 0 0 0
Pretax Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Minority Interest Expense 0 0 0 0 0
Net Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
EPS (Basic) (0.08) (0.07) (0.04) (0.11) (0.03)
Basic Shares Outstanding 48.17M 56.17M 69.35M 75.67M 100.69M
EPS (Diluted) (0.08) (0.07) (0.04) (0.11) (0.03)
Diluted Shares Outstanding 48.17M 56.17M 69.35M 75.67M 100.69M
EBITDA (1.99M) (3.03M) (2.02M) (5.39M) (3.37M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Advanced Medical Isotope Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 320,363 360,613 393,603 247,968 140,603
Cost of Goods Sold (COGS) incl. D&A 1.12M 1.47M 1.36M 556,020 1.76M
COGS excluding D&A 558,860 923,771 815,530 72,820 1.55M
Depreciation & Amortization Expense 562,671 545,192 546,388 483,200 208,632
Depreciation 537,671 539,499 539,720 472,038 199,743
Amortization of Intangibles 25,000 5,693 6,668 11,162 8,889
Gross Income (801,168) (1.11M) (968,315) (308,052) (1.62M)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.75M 2.47M 1.59M 5.56M 1.96M
Research & Development 67,006 - 481,677 973,611 416,161
Other SG&A 1.68M 2.47M 1.11M 4.59M 1.54M
Other Operating Expense 0 0 0 0 0
Unusual Expense 602,718 122,500 0 2.29M (1.44M)
EBIT after Unusual Expense (602,718) (122,500) 0 (2.29M) 1.44M
Non Operating Income/Expense 0 502,466 220,727 0 0
Non-Operating Interest Income 0 599 - 0 0
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 839,627 860,252 408,474 1.1M 1.6M
Gross Interest Expense 839,627 860,252 408,474 1.1M 1.6M
Interest Capitalized 0 0 0 0 0
Pretax Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Minority Interest Expense 0 0 0 0 0
Net Income (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (3.99M) (4.06M) (2.75M) (8.59M) (3.47M)
EPS (Basic) (0.08) (0.07) (0.04) (0.11) (0.03)
Basic Shares Outstanding 48.17M 56.17M 69.35M 75.67M 100.69M
EPS (Diluted) (0.08) (0.07) (0.04) (0.11) (0.03)
Diluted Shares Outstanding 48.17M 56.17M 69.35M 75.67M 100.69M
EBITDA (1.99M) (3.03M) (2.02M) (5.39M) (3.37M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
